miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma

Carcinogenesis

Volumn 35, Issue 3, 2014, Pages 554-563

  Lu, Juan ^a   Luo, Huanan ^a,b   Liu, Xiong ^a   Peng, Ying ^c   Zhang, Bao ^a   Wang, Lu ^a   Xu, Xia ^a   Peng, Xiaohong ^a   Li, Gang ^a   Tian, Wendong ^a   He, Ming Liang ^d,e   Kung, Hsiangfu ^d   Li, Xiang Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CHEMOKINE RECEPTOR CXCR4; MICRORNA 9; MITOGEN ACTIVATED PROTEIN KINASE P38; STROMAL CELL DERIVED FACTOR 1;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUCIFERASE ASSAY; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; RECEPTORS, CXCR4;

EID: 84893629103     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt354     Document Type: Article

References (47)

1. Yu,M.C. et al. (2002) Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol., 12, 421-429.
2. Hui,E.P. et al. (2004) Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer, 101, 300-306.
3. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
4. Esquela-Kerscher,A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
5. Calin,G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
6. Baer,C. et al. (2013) Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res., 73, 473-477.
7. Zhang,L.Y. et al. (2013) MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis, 34, 454-463.
8. Luo,Z. et al. (2013) miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis, 34, 415-425.
9. Liu,X. et al. (2012) MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle, 11, 2495-2506.
10. Deng,M. et al. (2011) miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J. Cell Sci., 124(Pt 17), 2997-3005.
11. Leucht,C. et al. (2008) MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat. Neurosci., 11, 641-648.
12. Ma,L. et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 12, 247-256.
13. Liu,S. et al. (2012) MicroRNA-9 up-regulates E-cadherin through inhibition of NF-?B1-Snail1 pathway in melanoma. J. Pathol., 226, 61-72.
14. Hu,X. et al. (2010) A microRNA expression signature for cervical cancer prognosis. Cancer Res., 70, 1441-1448.
15. Heller,G. et al. (2012) Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clin. Cancer Res., 18, 1619-1629.
16. Rodriguez-Otero,P. et al. (2011) Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br. J. Haematol., 155, 73-83.
17. Bandres,E. et al. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer, 125, 2737-2743.
18. Lujambio,A. et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA, 105, 13556-13561.
19. Hildebrandt,M.A. et al. (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene, 29, 5724-5728.
20. Minor,J. et al. (2012) Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol., 48, 73-78.
21. Wang,Z. et al. (2008) Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br. J. Cancer, 99, 1695-1703.
22. Tiscornia,G. et al. (2006) Production and purification of lentiviral vectors. Nat. Protoc., 1, 241-245.
23. Ou,D.L. et al. (2006) Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J. Pathol., 210, 363-373.
24. Lofgren,K.A. et al. (2011) Mammary gland specific expression of Brk/ PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Breast Cancer Res., 13, R89.
25. Jørgensen,S. et al. (2010) Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods, 52, 375-381.
26. Livak,K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
27. Lu,J. et al. (2011) MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res., 71, 225-233.
28. Franken,N.A. et al. (2006) Clonogenic assay of cells in vitro. Nat. Protoc., 1, 2315-2319.
29. Li,X.P. et al. (2006) Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Mol. Cancer Ther., 5, 1290-1298.
30. Teicher,B.A. et al. (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res., 16, 2927-2931.
31. Nie,K. et al. (2008) MicroRNA-mediated down-regulation of PRDM1/ Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am. J. Pathol., 173, 242-252.
32. Nass,D. et al. (2009) MiR-92b and miR-9/9*are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol., 19, 375-383.
33. Rotkrua,P. et al. (2011) MiR-9 downregulates CDX2 expression in gastric cancer cells. Int. J. Cancer, 129, 2611-2620.
34. Myatt,S.S. et al. (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res., 70, 367-377.
35. Guo,L.M. et al. (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J., 276, 5537-5546.
36. Tan,H.X. et al. (2010) MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med. Oncol., 27, 654-660.
37. Gao,F. et al. (2013) miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem. Biophys. Res. Commun., 431, 610-616.
38. Brenner,C. et al. (2005) Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J., 24, 336-346.
39. Di Croce,L. et al. (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science, 295, 1079-1082.
40. Klose,R.J. et al. (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci., 31, 89-97.
41. Cekaite,L. et al. (2012) MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia, 14, 868-879.
42. Zlotnik,A. et al. (2011) Homeostatic chemokine receptors and organ-specific metastasis. Nat. Rev. Immunol., 11, 597-606.
43. Wang,N. et al. (2005) Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. J. Transl. Med., 3, 26.
44. Hu,J. et al. (2005) The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma. Clin. Cancer Res., 11, 4658-4665.
45. Chou,J. et al. (2008) Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck, 30, 946-963.
46. Hiratsuka,S. et al. (2011) C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc. Natl Acad. Sci. USA, 108, 302-307.
47. Chen,G. et al. (2012) Inhibition of chemokine (CXC motif) ligand 12/ chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. J. Biol. Chem., 287, 12132-12141.